
Please try another search
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Name | Age | Since | Title |
---|---|---|---|
Steven I. Hochberg | 59 | 2018 | President, CEO & Director |
Jennifer Levin Carter | 57 | 2020 | Independent Director |
Gregory Sorensen | 59 | 2020 | Independent Director |
Mohit Kaushal | 42 | 2020 | Independent Director |
Richard Alan Barasch | 67 | 2020 | Executive Chairman |
Daniel Virnich | 45 | 2020 | CEO & Executive Director |
Bradford D. Hively | - | 2021 | Vice Chairman |
Mohit Kaushal | 45 | 2020 | Independent Director |
Richard Alan Barasch | 70 | 2019 | Chairman of the Board |
Karen Marie Johnson | 62 | 2021 | Independent Director |
Anne M. McGeorge | 63 | 2021 | Independent Director |
Mark L. Pacala | 68 | 2022 | Independent Director |
Gabe Ling | - | 2022 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review